[Answered] The equipercentile method does not actually equate scores on two different tests. Indicate ...

This topic contains a solution. Click here to go to the answer

Author Question: The equipercentile method does not actually equate scores on two different tests. Indicate ... (Read 70 times)

mspears3

Hero Member
Posts: 586

on: Jun 19, 2018

The equipercentile method does not actually equate scores on two different tests.

Indicate whether the statement is true or false

Question 2

The Kaufman Assessment Battery for Children (K-ABC) was designed to assess the mental
abilities of children between the ages of 6 and 16.

Indicate whether the statement is true or false

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

Christopher

Sr. Member
Posts: 316

Reply #1 on: Jun 19, 2018

Answer to Question 1

TRUE

Answer to Question 2

FALSE

mspears3

Member
Posts: 586

Reply 2 on: Jun 19, 2018

Excellent

dreamfighter72

Member
Posts: 355

Reply 3 on: Yesterday

TYSM

« previous next »

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

Signs and symptoms that may signify an eye tumor include general blurred vision, bulging eye(s), double vision, a sensation of a foreign body in the eye(s), iris defects, limited ability to move the eyelid(s), limited ability to move the eye(s), pain or discomfort in or around the eyes or eyelids, red or pink eyes, white or cloud spots on the eye(s), colored spots on the eyelid(s), swelling around the eyes, swollen eyelid(s), and general vision loss.

Did you know?

The horizontal fraction bar was introduced by the Arabs.

Did you know?

About 600,000 particles of skin are shed every hour by each human. If you live to age 70 years, you have shed 105 pounds of dead skin.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.